Abbott Biotechnology Ltd. – Trademark Portfolio

Entity Type: 03

Abbott Biotechnology Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HUMIRA. The owner is based in Hamilton.

Clarendon House, 2 Church Street

Hamilton HM11 , BM

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Abbott Biotechnology Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Abbott Biotechnology Ltd. have?

Abbott Biotechnology Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does Abbott Biotechnology Ltd. file in?

Abbott Biotechnology Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Abbott Biotechnology Ltd.'s most well-known trademarks?

Abbott Biotechnology Ltd.'s registered trademark portfolio includes well-known marks such as HUMIRA. These are among 2 currently registered trademarks in the portfolio.

What is Abbott Biotechnology Ltd.'s trademark registration success rate?

Abbott Biotechnology Ltd. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.